Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 281

Results For "US"

9610 News Found

Mumbai’s Apex Hospital achieves landmark 607 knee replacement surgeries in FY26
Hospitals | April 11, 2026

Mumbai’s Apex Hospital achieves landmark 607 knee replacement surgeries in FY26

The event also featured discussions on emerging trends in joint replacement surgery


ISDE India Edition 2026 spotlights minimally invasive therapies for esophageal cancer
Hospitals | April 11, 2026

ISDE India Edition 2026 spotlights minimally invasive therapies for esophageal cancer

The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies


CHRI, PATH and GSK Cares launch AMR Safe Disposal Innovation Challenge 2026
Public Health | April 11, 2026

CHRI, PATH and GSK Cares launch AMR Safe Disposal Innovation Challenge 2026

The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste


AIG Hospitals partners with ICMR to boost digital health and translational research
Hospitals | April 11, 2026

AIG Hospitals partners with ICMR to boost digital health and translational research

The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives


Apollo Hospitals Chennai performs India’s first adaptive deep brain stimulation for Parkinson’s
Hospitals | April 11, 2026

Apollo Hospitals Chennai performs India’s first adaptive deep brain stimulation for Parkinson’s

Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply


Actinium Pharma unveils groundbreaking data on radiotherapy platform at AACR 2026
News | April 10, 2026

Actinium Pharma unveils groundbreaking data on radiotherapy platform at AACR 2026

The presentations will showcase previously undisclosed data highlighting the expanding potential of Actinium’s Ac-225 radiotherapy platform across both solid tumors and hematologic malignancies


Glycomine completes enrollment in Phase 2b trial for rare genetic disorder
Clinical Trials | April 10, 2026

Glycomine completes enrollment in Phase 2b trial for rare genetic disorder

The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation


Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing
News | April 10, 2026

Zeto gains FDA nod for new outpatient EEG system promising faster brain health testing

The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE


Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses
Digitisation | April 10, 2026

Beacon raises $132M+ to bring AI-driven sleep diagnostics to masses

The device aims to bring precision neuroscience into clinical trials, accelerating drug development


Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners
News | April 10, 2026

Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners

The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure